T1	AdverseReaction 83 94	gout flares
T2	AdverseReaction 482 518	cardiovascular thromboembolic events
T3	AdverseReaction 710 725	hepatic failure
T4	AdverseReaction 737 742	fatal
T5	AdverseReaction 1106 1116	gout flare
T6	AdverseReaction 1546 1582	cardiovascular thromboembolic events
T7	AdverseReaction 1584 1605	cardiovascular deaths
T8	AdverseReaction 1617 1639	myocardial infarctions
T9	Severity 1607 1616	non-fatal
T10	AdverseReaction 1655 1662	strokes
T11	Severity 1645 1654	non-fatal
T12	AdverseReaction 2074 2089	hepatic failure
T13	AdverseReaction 2054 2059	fatal
T14	AdverseReaction 2252 2275	transaminase elevations
T15	Severity 2289 2326	three times the upper limit of normal
T16	AdverseReaction 55 65	Gout Flare
T17	AdverseReaction 441 462	Cardiovascular Events
T18	AdverseReaction 668 683	Hepatic Effects
E1	AdverseReaction:T1
E2	AdverseReaction:T2
E3	AdverseReaction:T3
E4	AdverseReaction:T4
E5	AdverseReaction:T5
E6	AdverseReaction:T6
E7	AdverseReaction:T7
E8	AdverseReaction:T8 Effect:E9
E9	Severity:T9
E10	AdverseReaction:T10 Effect:E11
E11	Severity:T11
E12	AdverseReaction:T12
E13	AdverseReaction:T13
E14	AdverseReaction:T14 Effect:E15
E15	Severity:T15
E16	AdverseReaction:T16
E17	AdverseReaction:T17
E18	AdverseReaction:T18
A1	CUI E1 C1619733
A2	UMLS-Preferred-Name E1 Gout flare
A3	MEDDRA-PT E1 Gout
A4	MEDDRA-PT-ID E1 10018627
A5	LLT E1 Gout flare
A6	LLT-ID E1 10064900
A7	CUI E2 C0040038
A8	UMLS-Preferred-Name E2 Thromboembolism
A9	MEDDRA-PT E2 Embolism
A10	MEDDRA-PT-ID E2 10061169
A11	LLT E2 Thromboembolic event
A12	LLT-ID E2 10043565
A13	CUI E3 C0085605
A14	UMLS-Preferred-Name E3 Liver Failure
A15	MEDDRA-PT E3 Hepatic failure
A16	MEDDRA-PT-ID E3 10019663
A17	CUI E4 C1306577
A18	UMLS-Preferred-Name E4 Death (finding)
A19	MEDDRA-PT E4 Death
A20	MEDDRA-PT-ID E4 10011906
A21	CUI E5 C1619733
A22	UMLS-Preferred-Name E5 Gout flare
A23	MEDDRA-PT E5 Gout
A24	MEDDRA-PT-ID E5 10018627
A25	LLT E5 Gout flare
A26	LLT-ID E5 10064900
A27	CUI E6 C0040038
A28	UMLS-Preferred-Name E6 Thromboembolism
A29	MEDDRA-PT E6 Embolism
A30	MEDDRA-PT-ID E6 10061169
A31	LLT E6 Thromboembolic event
A32	LLT-ID E6 10043565
A33	CUI E7 C0376297
A34	UMLS-Preferred-Name E7 Cardiac Death
A35	MEDDRA-PT E7 Cardiac death
A36	MEDDRA-PT-ID E7 10049993
A37	CUI E8 C0027051
A38	UMLS-Preferred-Name E8 Myocardial Infarction
A39	MEDDRA-PT E8 Myocardial infarction
A40	MEDDRA-PT-ID E8 10028596
A41	CUI E10 C0038454
A42	UMLS-Preferred-Name E10 Cerebrovascular accident
A43	MEDDRA-PT E10 Cerebrovascular accident
A44	MEDDRA-PT-ID E10 10008190
A45	LLT E10 Stroke
A46	LLT-ID E10 10042244
A47	CUI E12 C0085605
A48	UMLS-Preferred-Name E12 Liver Failure
A49	MEDDRA-PT E12 Hepatic failure
A50	MEDDRA-PT-ID E12 10019663
A51	CUI E13 C1306577
A52	UMLS-Preferred-Name E13 Death (finding)
A53	MEDDRA-PT E13 Death
A54	MEDDRA-PT-ID E13 10011906
A55	CUI E14 C0438717
A56	UMLS-Preferred-Name E14 Transaminases increased
A57	MEDDRA-PT E14 Transaminases increased
A58	MEDDRA-PT-ID E14 10054889
A59	CUI E16 C1619733
A60	UMLS-Preferred-Name E16 Gout flare
A61	MEDDRA-PT E16 Gout
A62	MEDDRA-PT-ID E16 10018627
A63	LLT E16 Gout flare
A64	LLT-ID E16 10064900
A65	CUI E17 C1320716
A66	UMLS-Preferred-Name E17 Cardiovascular event
A67	MEDDRA-PT E17 Cardiovascular symptom
A68	MEDDRA-PT-ID E17 10075534
A69	CUI E18 C0235378
A70	UMLS-Preferred-Name E18 Hepatotoxicity
A71	MEDDRA-PT E18 Hepatotoxicity
A72	MEDDRA-PT-ID E18 10019851
A73	LLT E18 Hepatotoxic effect
A74	LLT-ID E18 10019850
